Chemed Corp. Stock
Chemed Corp. Stock
Chemed Corp. shows a slight decrease today, losing -€5.000 (-0.930%) compared to yesterday.
Our community is currently high on Chemed Corp. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 588 € shows a slightly positive potential of 9.91% compared to the current price of 535.0 € for Chemed Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Chemed Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Chemed Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | -0.930% | - | - | - | - | - | - |
| Amn Healthcare Svs | - | 1.802% | 7.619% | -35.057% | -15.672% | -22.069% | 26.895% |
| Ensign Group Inc. | 0.910% | 0.917% | 0.000% | - | 6.796% | - | - |
| Select Medical Holdings | 0.630% | 5.229% | - | - | - | - | - |
Comments
Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $625.00 to $650.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the
Chemed Reports First-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an